XML 59 R41.htm IDEA: XBRL DOCUMENT v3.8.0.1
Earnings per Share (Tables)
 12 Months Ended
Dec. 31, 2017
Earnings Per Share [Abstract]  
Schedule of Basic and Diluted Earnings per Share
The following table sets forth the computation of basic and diluted earnings per share for the years ended December 31, 2017, 2016 and 2015.
 
Year Ended December 31,
 
2017
 
2016
 
2015
 
(In thousands, except per share amounts)
Amounts attributable to The Medicines Company:
 

 
 

 
 

(Loss) income from continuing operations
$
(607,695
)
 
$
20,564

 
$
(134,806
)
Loss from discontinued operations, net of tax
(100,678
)
 
(139,682
)
 
(217,950
)
Net loss attributable to The Medicines Company
$
(708,373
)
 
$
(119,118
)
 
$
(352,756
)
 
 
 
 
 
.

Weighted average common shares outstanding, basic
72,356

 
69,909

 
66,809

Plus: net effect of dilutive stock options, warrants, restricted common shares and shares issuable upon conversion of Notes
—

 
3,113

 
—

Weighted average common shares outstanding, diluted
72,356

 
73,022

 
66,809

 
 
 
 
 
 
Basic (loss) earnings per common share attributable to The Medicines Company:
 
 
 
 
 
(Loss) earnings from continuing operations
$
(8.40
)
 
$
0.29

 
$
(2.02
)
Loss from discontinued operations
(1.39
)
 
(2.00
)
 
(3.26
)
Basic loss per share
$
(9.79
)
 
$
(1.71
)
 
$
(5.28
)
 
 
 
 
 
 
Diluted (loss) earnings per common share attributable to The Medicines Company:
 
 
 
 
 
(Loss) earnings from continuing operations
$
(8.40
)
 
$
0.28

 
$
(2.02
)
Loss from discontinued operations
(1.39
)
 
(1.91
)
 
(3.26
)
Diluted loss per share
$
(9.79
)
 
$
(1.63
)
 
$
(5.28
)